tradingkey.logo

BRIEF-Bayer: Applies For EU Approval For 6-Month Treatment Interval With Eylea 8mg

ReutersFeb 10, 2025 8:04 AM

- Bayer AG BAYGn.DE:

  • BAYER: APPLIES FOR APPROVAL IN THE EU FOR 6-MONTH TREATMENT INTERVAL WITH EYLEA 8MG

  • BAYER: APPLICATION BASED ON POSITIVE LONG-TERM RESULTS FROM PULSAR, PHOTON TRIALS OVER THREE YEARS

Source text: [ID:]

Further company coverage: [BAYGn.DE]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI